Simulations Plus, Inc. reported $82M of revenue over the trailing twelve months, +2.1% on the year before. 10 reported series are charted on this page, each one as filed. Revenue, trailing twelve months: $82M (to Q3 2026). Net income: $8.1M, trailing twelve months to Q3 2026. Free cash flow: $25M, trailing twelve months to Q3 2026. Operating margin: 13%, trailing twelve months to Q3 2026.

SLPSimulations Plus, Inc.

Healthcare

$18.50+19% 1Y

$18.50

$11.3652 weeks$20.84

SLP as reported

Simulations Plus, Inc. reported $82M of revenue over the trailing twelve months, +2.1% on the year before. 10 reported series are charted on this page, each one as filed.

$82M

Revenue, trailing twelve months · to Q3 2026 · +2.1% against the twelve months before

Net income: $8.1M
Net income · −113% year on year · trailing twelve months to Q3 2026
Free cash flow: $25M
Free cash flow · +79% year on year · trailing twelve months to Q3 2026
Operating margin: 13%
Operating margin · trailing twelve months to Q3 2026

Details›

Every series Ryufin has for SLP, trailing twelve months
Series	Latest	Year on year	As of
Revenue	$82M	+2.1%	Q3 2026
Net income	$8.1M	−113%	Q3 2026
EPS	$0.40	−113%	Q3 2026
Gross margin	63%	n/a	Q3 2026
Operating margin	13%	n/a	Q3 2026
Net margin	8.7%	n/a	Q3 2026
ROE	−36%	n/a	Q3 2026
ROA	−33%	n/a	Q3 2026
Free cash flow	$25M	+79%	Q3 2026
P/E	46.3	n/a	today

Every figure straight from the statements filed with the SEC, no scoring. Per-share figures and share counts are restated for stock splits, so a split never shows up as a collapse. Open a series for its full history.